Modified Oligos

68 view(s)

TL Rapid Isolation of Bacteria-Specific Aptamers with a Novel Non-SELEX-Based Method

23 view(s)

TL CRISPR for SARS-CoV-2 to Combat COVID-19

4 view(s)

TL April is Parkinson’s Awareness Month – 2020

22 view(s)

TL Anti-Prion Antisense Oligonucleotides (ASOs): A Possible Therapy for Prion-Related Diseases such as Creutzfeldt–Jakob Disease (CJD)

125 view(s)

TL A Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides

141 view(s)

TL Doubling Down on siRNAs in the Brain

42 view(s)

TL Post-Transcriptional Labeling of RNA Using Suzuki–Miyaura Cross-Coupling

102 view(s)

TL Enzymatic Synthesis of Base-Modified RNA by T7 RNA Polymerase

119 view(s)

TL Xeno Nucleic Acids (XNAs) Revisited

48 view(s)

TL An Antisense Oligonucleotide Is the First Drug to Demonstrate Reduction of Mutant Huntingtin Protein in Humans

TL Biomarker TL antisense

Modified Oligos

TL Rapid Isolation of Bacteria-Specific Aptamers with a Novel Non-SELEX-Based Method

TL CRISPR for SARS-CoV-2 to Combat COVID-19

TL April is Parkinson’s Awareness Month – 2020

TL Anti-Prion Antisense Oligonucleotides (ASOs): A Possible Therapy for Prion-Related Diseases such as Creutzfeldt–Jakob Disease (CJD)

TL A Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides

TL Doubling Down on siRNAs in the Brain

TL Post-Transcriptional Labeling of RNA Using Suzuki–Miyaura Cross-Coupling

TL Enzymatic Synthesis of Base-Modified RNA by T7 RNA Polymerase

TL Xeno Nucleic Acids (XNAs) Revisited

TL An Antisense Oligonucleotide Is the First Drug to Demonstrate Reduction of Mutant Huntingtin Protein in Humans

Email Sign Up

Modified Oligos

Email Sign Up